English

dc.contributor.authorCakir, B
dc.contributor.authorCakir, ADU
dc.contributor.authorSapmaz, SY
dc.contributor.authorBilac, O
dc.contributor.authorTaneli, F
dc.contributor.authorKandemir, H
dc.date.accessioned2024-07-18T11:55:38Z
dc.date.available2024-07-18T11:55:38Z
dc.description.abstractROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
dc.identifier.issn2162-2973
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/6563
dc.language.isoArticle; Early Access
dc.publisher2162-2965
dc.subjectBackgroundMethamphetamine is a substance that causes neurotoxicity and its use is increasing in recent years. Literature highlights cognitive impairment resulting from Methamphetamine use. The aim of the present study is to evaluate the relationship between cognitive impairment and inflammatory processes in adolescents with Methamphetamine use disorder.MethodsThe study included 69 adolescents aged 15-19 years, comprising 37 participants with Methamphetamine Use Disorder and 32 healthy controls. Central Nervous System Vital Signs was used to detect cognitive impairment. Childhood Trauma Questionnaire-33 and The Children's Depression Inventory scales were used. In addition, venous blood was collected from the volunteers. Biochemical parameters (IL-1beta, IL-6, TNF-a, BDNF, FAM19A5, TAS, TOS) were analyzed.ResultsOur study showed that (I) IL-6 and TNF-a levels of Methamphetamine users were lower than the healthy group; (II) BDNF levels of Methamphetamine users were higher than the healthy group; (III) mean Neurocognitive Index in cognitive tests of Methamphetamine using adolescents was negatively correlated with duration of Methamphetamine use and BDNF levels.ConclusionsOur study suggests that Methamphetamine use may have a negative effect on cognitive functions.
dc.titleEnglish
dc.typeMICROVASCULAR ENDOTHELIAL-CELLS
dc.typeNF-KAPPA-B
dc.typeTNF-ALPHA
dc.typeCHILDHOOD TRAUMA
dc.typeUSE DISORDER
dc.typeDRUG-USE
dc.typeBRAIN
dc.typeABUSE
dc.typeRELIABILITY
dc.typeVALIDITY

Files